Control system for automatic transmission
    1.
    发明授权
    Control system for automatic transmission 失效
    自动变速器控制系统

    公开(公告)号:US4885960A

    公开(公告)日:1989-12-12

    申请号:US238610

    申请日:1988-08-31

    摘要: A creep phenomenon of an automotive vehicle is prevented by an arrangement which is provided with an anti-creep mode which is operative to change the gear automatically to a speed range having a relatively low speed reduction ratio when the vehicle is at rest. A double engagement within the transmission and resulting oscillations which would occur when a special operation is performed is prevented. At this end, a time delay is provided before shifting to the anti-creep mode when the vehicle is at rest and the throttle valve opening of an engine is equal to or less than a given value.

    摘要翻译: 通过设置有抗蠕变模式的装置来防止机动车辆的蠕变现象,所述抗蠕变模式可在车辆静止时自动地将齿轮改变到具有相对低的减速比的速度范围。 防止在执行特殊操作时发生的传输和产生的振荡中的双重接合。 为此,在车辆静止而发动机的节气门开度为规定值以下时,在变换为抗蠕变模式之前,提供时间延迟。

    MEDICAL ADHESIVE
    2.
    发明申请
    MEDICAL ADHESIVE 有权
    医用胶粘剂

    公开(公告)号:US20140018510A1

    公开(公告)日:2014-01-16

    申请号:US14005906

    申请日:2012-03-09

    IPC分类号: A61L24/04

    摘要: The present invention is directed to providing a safe medical adhesive, a cured body of which is hard to be degraded and decomposed and thus stable and the cured body generates less amount of acid, aldehyde, etc. due to degradation/decomposition. The medical adhesive includes a hydrophilic urethane prepolymer (UP) obtained by reacting a polyisocyanate component (A) containing a fluorine-containing non-aromatic polyisocyanate compound (A1) as an essential ingredient and a polyol component (B) containing a hydrophilic polyol (B1) as an essential ingredient, wherein a chlorine content in a chlorine-containing organic compound based on the weight of the hydrophilic urethane prepolymer (UP) is 0.005 wt % or less.

    摘要翻译: 本发明旨在提供一种安全的医用粘合剂,其固化体难以降解和分解,因此稳定,固化体由于降解/分解而产生较少量的酸,醛等。 医用胶粘剂包括通过使含有含氟非芳香族多异氰酸酯化合物(A1)作为必需成分的多异氰酸酯成分(A)与含有亲水性多元醇(B1)的多元醇成分(B)反应而得到的亲水性氨基甲酸酯预聚物(UP) )作为必要成分,其中,基于亲水性氨基甲酸酯预聚物(UP)的重量,含氯有机化合物中的氯含量为0.005重量%以下。

    IMAGE FORMING APPARATUS AND CONTROLLING METHOD
    5.
    发明申请
    IMAGE FORMING APPARATUS AND CONTROLLING METHOD 有权
    图像形成装置和控制方法

    公开(公告)号:US20100209127A1

    公开(公告)日:2010-08-19

    申请号:US12700064

    申请日:2010-02-04

    IPC分类号: G03G15/08

    CPC分类号: G03G15/09 G03G15/5008

    摘要: The disclosed image forming apparatus includes a rotatable image holding body configured to hold an electrostatic latent image on a surface of the image holding body, a developing device including a forward rotation developing roller rotatable in a same rotational direction as that of the rotatable image holding body and a reverse rotation developing roller rotatable in a reverse rotational direction to that of the rotatable image holding body, which supply a two-component developer to the surface of the image holding body to form a toner image corresponding to the electrostatic latent image, and a control unit configured to control rotation of the image holding body, the forward rotation developing roller, and the reverse rotation developing roller to supply the two-component developer. The control unit controls the rotation of the image holding body to start after a predetermined time period from starting the rotation of the forward rotation developing roller and the reverse rotation developing roller.

    摘要翻译: 所公开的图像形成装置包括:可旋转图像保持体,其构造成将静电潜像保持在图像保持体的表面上;显影装置,包括可旋转的旋转图像保持体的旋转方向的正转显影辊 以及反转显影辊,其以与可旋转图像保持体相反的旋转方向旋转,将双组分显影剂供应到图像保持体的表面,以形成与静电潜像对应的调色剂图像;以及 控制单元,被配置为控制图像保持体,正向旋转显影辊和反转显影辊的旋转,以供应双组分显影剂。 控制单元控制图像保持体的旋转,以在从正向旋转显影辊和反转显影辊的旋转开始的预定时间段之后开始。

    Antibody against enzyme specifically cleaving von villebrand factor and assay system using the same
    9.
    发明申请
    Antibody against enzyme specifically cleaving von villebrand factor and assay system using the same 有权
    针对酶的抗体特异性切割von villebrand因子和使用其的测定系统

    公开(公告)号:US20060251655A1

    公开(公告)日:2006-11-09

    申请号:US10529009

    申请日:2003-09-25

    CPC分类号: C12N9/6489 C07K16/40

    摘要: It is intended to provide an antibody showing immunoreactivity selectively to ADAMTS-13 and applications of this antibody in epitope analysis or diagnosis of an ADAMTS-13 autoantibody-positive patient. Alternatively, it is intended to provide a process for producing and use of a modified ADAMTS-13 molecule partially deleted aiming at the application in pharmaceutical products. An antibody specific for ADAMTS-13 which can be obtained from a warm-blooded animal immunized and sensitized with a polypeptide containing a part or the whole of ADAMTS-13 amino acid sequence; a process for producing an antibody comprising a step of immunizing and sensitizing a warm-blooded animal with a polypeptide containing a part or the whole of ADAMTS-13 amino acid sequence; use of the above-described antibody including a method of detecting and purifying ADAMTS-13; and a modified ADAMTS-13 molecule partially deleted are provided.

    摘要翻译: 旨在提供一种抗体,显示ADAMTS-13的免疫反应性和该抗体在ADAMTS-13自身抗体阳性患者的表位分析或诊断中的应用。 或者,旨在提供一种制备和使用针对在药物产品中应用的部分缺失的修饰的ADAMTS-13分子的方法。 对于ADAMTS-13特异的抗体,其可从用含有部分或全部ADAMTS-13氨基酸序列的多肽免疫并致敏的温血动物获得; 一种制备抗体的方法,其包括用含有部分或全部ADAMTS-13氨基酸序列的多肽对温血动物进行免疫和致敏的步骤; 使用上述抗体,包括检测和纯化ADAMTS-13的方法; 并提供部分缺失的修饰的ADAMTS-13分子。